Celcuity LLC (CELC)

Healthcare · Biotechnology
$67.94 +0.10% on the day Market cap $3.5B 52-week range $45.03 to $151.02 Prices as of Oct 11, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Celcuity LLC's free cash flow was negative in fiscal 2025, so a cash-flow reverse DCF doesn't give a meaningful answer. The Modeling tab works from revenue and margins instead.

Fundamental grade

F

Five factors scored 1 to 9 from CELC's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation1
Profitability0
Financial health9

Results from SEC filings

Fiscal years, from Celcuity LLC's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.

Fiscal year20212022202320242025
Revenue—————
Net income-$30M-$40M-$64M-$112M-$177M
Free cash flow-$20M-$36M-$54M-$84M-$154M
EPS (diluted)-$2.21-$2.64-$2.69-$2.83-$3.79
Operating margin—————

Superinvestors who own CELC

From each investor's latest 13F filing (what a 13F shows). 2 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Hersh Cohen
ClearBridge Investments
Trimmed $8M0.01%Q2 2026
Cliff Asness
AQR Capital Management
Trimmed $1M0.0%Q2 2026

Insider buying

Open-market purchases by Celcuity LLC's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

No open-market insider purchases of CELC in the last 12 months. Most insider activity is selling and option exercises, which aren't shown here.

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when CELC trades at or below it.

$

New accounts get 7 days of Pro, price alerts included. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

Are Celcuity LLC insiders buying the stock?

No open-market insider purchases of CELC in the last 12 months, according to SEC Form 4 filings.

Which superinvestors own Celcuity LLC?

2 of the superinvestors Investingly tracks hold CELC in their latest 13F, including Hersh Cohen, Cliff Asness.

Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.